Lucentis®
Lucentis® (ranibizumab) is another well-established treatment for retinal conditions such as wet AMD, diabetic macular edema, and retinal vein occlusion. Like Eylea, Lucentis is an anti-VEGF medication that blocks abnormal blood vessel growth and reduces swelling in the retina. By controlling these processes, Lucentis helps protect vision and may even improve sight in many patients.
How Lucentis Works
Lucentis works by binding directly to VEGF proteins, stopping them from signaling the growth of fragile blood vessels that leak fluid. This prevents further retinal damage and helps reduce swelling. Lucentis was one of the first FDA-approved drugs in this class and has a strong track record of safety and effectiveness in protecting vision.
What to Expect During Treatment
Lucentis injections are performed in the office with careful attention to patient comfort. Your eye is numbed with anesthetic drops, and the injection itself takes only a few seconds. Most patients feel minimal discomfort, and any irritation after treatment usually resolves within a day. Treatment is often started with monthly injections, though your doctor may adjust the schedule as your eye responds.
Benefits of Lucentis
Lucentis has been proven in clinical studies to help many patients maintain or even improve their vision over time. Because retinal diseases are chronic, staying consistent with treatment is key to protecting your sight. Your doctor will guide you through a personalized plan tailored to your condition and response to therapy.
At East Florida Eye Institute, we are proud to provide Lucentis injections as part of our advanced retinal treatments. Our skilled doctors and caring staff ensure that every visit is comfortable, efficient, and focused on your vision health. With ongoing monitoring and follow-up, we tailor care to your needs so you can feel confident about your treatment journey.